Showing 2771-2780 of 5621 results for "".
- US Military Develops Mobile Application to Treat Eye Injurieshttps://modernod.com/news/us-military-develops-mobile-application-to-treat-eye-injuries/2476479/The U.S. military medical researchers are developing a mobile application to connect combat medics with on-call ophthalmologists either in-theater or at a clinic to treat eye injuries of soldiers in the field, according to a
- Fraunhofer IAP Developing Contact lenses With Medicine and Sugarhttps://modernod.com/news/fraunhofer-iap-developing-contact-lenses-with-medicine-and-sugar/2476476/Researchers at the Fraunhofer Institute for Applied Polymer Research IAP are working with Israeli and German partners to develop long-wearing contact lenses that can release medicine. The active ingredient is encapsulated in liposomes and bound to the inside of the contact lenses. This enables it
- Ocular Therapeutix Announces Supplemental NDA Accepted by FDA for Dextenzahttps://modernod.com/news/ocular-therapeutix-announces-supplemental-nda-accepted-by-fda-for-dextenza/2476429/Ocular Therapeutix announced the FDA has accepted the filing of the supplemental new drug application (sNDA) for Dextenza (dexamethasone ophthalmic insert) to include the treatment of ocular inflammation following ophthalmic surgery in its label. The notice of acceptance confirms the FDA has comp
- FDA Prepares for Possible Device Shortages After Gas Leaks Lead to Closure of Sterilization Planthttps://modernod.com/news/fda-prepares-for-possible-device-shortages-after-gas-leaks-lead-to-closure-of-sterilization-plant/2479583/The FDA is working to prevent potential shortages of medical devices after the closure of an Illinois sterilization plant, which was due to a state environmental protection order, according to a
- IOT Introduces EVOlens Machine Learning System Designed to Increase Patient Satisfaction Over Timehttps://modernod.com/news/iot-introduces-evolens-machine-learning-system-designed-to-increase-patient-satisfaction-over-time/2479585/Indizen Optical Technologies (IOT) has introduced the EVOlens, a recommendation system that objectively chooses the best progressive design for each patient based on the feedback of wearers with similar visual profile
- RegeneRx and Lee’s Pharm to Accelerate RGN-259 Development in Chinahttps://modernod.com/news/regenerx-and-lees-pharm-to-accelerate-rgn-259-development-in-china/2476417/RegeneRx Biopharmaceuticals and Lee’s Pharmaceutical Holdings, a Hong Kong-based pharmaceutical company, are accelerating development of RGN-259 in China for ophthalmic indications. Lee’s Pharm previously licensed RGN-2
- Johnson & Johnson Vision’s Investigational Antihistamine-Releasing Contact Lens Demonstrates Positive Phase 3 Resultshttps://modernod.com/news/johnson-johnson-visions-investigational-antihistamine-releasing-contact-lens-demonstrates-positive-phase-3-results/2476418/Johnson & Johnson Vision announced that results from two phase 3 clinical studies evaluating the company’s investigational antihistamine-releasing contact lens (etafilcon A with 0.019 mg ketotifen) were published in the journal Cornea. The results demonstrated that patients weari
- Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kithttps://modernod.com/news/q-biomed-and-mannin-research-to-develop-gdf15-biomarker-glaucoma-diagnostic-kit/2476396/Q BioMed announced that its technology partner Mannin Research has entered into a research collaboration with the Biointerfaces Institute at McMaster University in Ontario, Canada to develop a GDF15 biomarker diagnostic kit for monitoring glaucoma severity and progression. This enabling te
- Fluoride Can Cause Degenerative Eye Diseases, Study Showshttps://modernod.com/news/fluoride-can-cause-degenerative-eye-diseases-study-shows/2476388/Fluoride contributes to degenerative eye diseases such as cataracts, age related macular degeneration (AMD) and glaucoma, reports DT Waugh in the
- Acucela Signs Agreement to Develop a Compact OCT for NASA’s Deep Space Missionshttps://modernod.com/news/acucela-signs-agreement-to-develop-a-compact-oct-for-nasas-deep-space-missions/2476385/Acucela announced that the company signed the agreement with the Translational Research Institute for Space Health (TRISH) to develop a compact OCT device for NASA’s Deep Space missions. Approximately 63% of long-duration spaceflight crewmembers present with one or more signs of Spacefligh